Nexxus Iberia acquires majority stake in Skinclinic to drive international expansion

Nexxus Iberia has acquired a majority stake in Skinclinic, a leading Spanish developer and manufacturer of professional skincare and personal care products.

The investment marks the fourth deal from Nexxus Iberia Fund II, which has secured over €240m in commitments, and reflects the firm’s continued focus on high-growth businesses in the health and wellness sector.

Based in Alicante, Skinclinic has built a strong presence in Spain, serving over 3,000 professional clients in the aesthetic medicine and dermatology space, while also operating an e-commerce platform and providing third-party manufacturing services. The company, which generates annual sales of €12m and employs over 90 staff, is known for its high-quality formulations and innovative product range for facial and body care.

Skinclinic founder Cayetano Gutiérrez will remain at the helm, continuing to lead the company’s operations alongside a team strengthened by the appointment of José Luis García-Pons as CEO. García-Pons brings extensive experience from the cosmetics and food supplements sectors, supporting Skinclinic’s ambition to accelerate international growth, particularly in Europe and Latin America.

Nexxus Iberia partner Javier Onieva commented: “Skinclinic is a perfect fit for our strategy of partnering with ambitious entrepreneurs in health and wellness. We see significant global potential, backed by a strong team, superior products, and a differentiated brand.”

The transaction also reflects Nexxus Iberia’s track record of supporting growth-stage businesses in the health and wellness sector, following investments in W Clinics (Dorsia), Bienzobas, Mercurius, Vivo Diagnóstico, Contenur, and Marsanz.

Nexxus Iberia received advisory support from Auren (M&A), Grant Thornton (legal), Deloitte (due diligence), Strategy& (commercial), Ramón y Cajal (legal), EY (ESG), and Aon (insurance). The sellers were advised by Garrigues (legal) and Clearwater International (M&A).

Source: Capital Riesgo 

If you think we missed any important news, please do not hesitate to contact us at news@pe-insights.com

Can`t stop reading? Read more.